Skip to main content
Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.990
+0.040 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed

Cryo-Cell International Revenue

Cryo-Cell International had revenue of $7.83M in the quarter ending August 31, 2025, a decrease of -2.99%. This brings the company's revenue in the last twelve months to $31.75M, down -0.29% year-over-year. In the fiscal year ending November 30, 2024, Cryo-Cell International had annual revenue of $31.99M with 2.05% growth.

Revenue (ttm)
$31.75M
Revenue Growth
-0.29%
P/S Ratio
1.01
Revenue / Employee
$369,157
Employees
86
Market Cap
32.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202431.99M642.41K2.05%
Nov 30, 202331.34M1.01M3.32%
Nov 30, 202230.34M1.45M5.03%
Nov 30, 202128.88M-2.26M-7.26%
Nov 30, 202031.15M-668.98K-2.10%
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

CCEL News

More News